Black Rock Inc. Centogene N.V. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Centogene N.V. stock. As of the latest transaction made, Black Rock Inc. holds 18,296 shares of CNTG stock, worth $2,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,296

Previous 18,296 -0.0%

Holding current value

$2,012

Previous $12,000 50.0%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.65 - $1.25 $2,133 - $4,102	-3,282 Reduced 15.21%	18,296 $12,000
Q2 2022 Aug 12, 2022	BUY	$2.06 - $4.25 $451 - $930	219 Added 1.03%	21,578 $51,000
Q1 2022 May 12, 2022	SELL	$3.3 - $5.44 $188 - $310	-57 Reduced 0.27%	21,359 $90,000
Q4 2021 Feb 10, 2022	SELL	$4.56 - $10.56 $5,180 - $11,996	-1,136 Reduced 5.04%	21,416 $111,000
Q2 2021 Aug 11, 2021	BUY	$9.02 - $12.93 $203,419 - $291,597	22,552 New	22,552 $236,000

Others Institutions Holding CNTG

# of Institutions

Shares Held

33.6K

Call Options Held

Put Options Held

Barclays PLC London, X0

15.3K
Shares

$1,688
0.0% of portfolio

View Full List

About Centogene N.V.

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

More about CNTG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account